BLISS GVS PHARMA
Smallcap | BSE
Sector
Index
Here's the live share price of Bliss GVS Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
5.00₹ 25.95
As on Aug 18, 2026, 04:01 PM IST
Source: Dion Global
Bliss GVS Pharma Price Performance
Today's LowToday's High
₹504.10₹545.45
₹545.45
52 Weeks' Low52 Weeks' High
₹118.35₹552.90
₹545.45
Open Price
₹527.00
Prev. Close
₹519.50
Volume
31,844
Source: Dion Global
Bliss GVS Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Bliss GVS Pharma | 11.73 | 11.46 | 92.67 | 140.71 | 213.84 | 80.14 | 37.84 |
| Sun Pharmaceutical Industries | -3.03 | -4.08 | -0.31 | 9.53 | 15.38 | 18.27 | 19.10 |
| Divi's Laboratories | 0.64 | 17.46 | 24.41 | 36.65 | 41.38 | 33.03 | 11.85 |
| Torrent Pharmaceuticals | 1.74 | -0.56 | 11.62 | 17.83 | 36.29 | 35.96 | 26.65 |
| Cipla | -2.03 | -0.67 | 1.56 | 7.73 | -7.56 | 5.04 | 9.52 |
| Zydus Lifesciences | -7.23 | -2.59 | 9.62 | 23.80 | 12.94 | 19.91 | 15.53 |
| Lupin | -1.75 | -10.22 | -2.69 | -0.15 | 13.05 | 27.71 | 18.03 |
| Mankind Pharma | -1.43 | -6.86 | -4.17 | 17.30 | -4.07 | 8.94 | 10.91 |
| Dr. Reddy's Laboratories | -1.54 | -3.50 | -11.50 | -7.76 | -5.20 | 0.17 | 4.72 |
| Laurus Labs | -1.45 | 16.37 | 34.90 | 77.70 | 105.10 | 68.21 | 21.23 |
| Aurobindo Pharma | -1.59 | 4.99 | 8.31 | 39.35 | 50.28 | 24.07 | 17.81 |
| Biocon | -2.50 | -4.18 | -2.33 | 9.37 | 14.84 | 17.42 | 2.47 |
| Alkem Laboratories | 0.09 | -3.21 | 0.14 | 1.87 | 1.58 | 12.99 | 7.57 |
| Glenmark Pharmaceuticals | 1.59 | 3.09 | -4.03 | 14.26 | 18.62 | 44.47 | 33.06 |
| Abbott India | -5.54 | -5.97 | -4.34 | 0.75 | -19.58 | 4.37 | 7.11 |
| Anthem Biosciences | 1.54 | 12.62 | 13.26 | 28.19 | 8.96 | 6.87 | 4.07 |
| GlaxoSmithKline Pharmaceuticals | 10.06 | 15.99 | 20.69 | 12.14 | 2.34 | 26.95 | 12.84 |
| Ipca Laboratories | 6.97 | 3.20 | 14.23 | 29.04 | 36.38 | 29.18 | 9.18 |
| Gland Pharma | -1.30 | 16.16 | 27.05 | 55.59 | 46.87 | 22.14 | -6.84 |
| Ajanta Pharma | 4.59 | 6.81 | 14.17 | 25.22 | 36.89 | 27.95 | 19.33 |
Source: Dion Global
Over the last one year, Bliss GVS Pharma has gained 213.84% compared to peers like Sun Pharmaceutical Industries (15.38%), Divi's Laboratories (41.38%), Torrent Pharmaceuticals (36.29%). From a 5 year perspective, Bliss GVS Pharma has outperformed peers relative to Sun Pharmaceutical Industries (19.10%) and Divi's Laboratories (11.85%).
Bliss GVS Pharma Financials
Source: Dion Global
Bliss GVS Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 507.96 | 521.67 |
| 10 | 498.18 | 507.78 |
| 20 | 479.01 | 496.01 |
| 50 | 483.29 | 465.81 |
| 100 | 384.68 | 405.31 |
| 200 | 281.34 | 325.77 |
Source: Dion Global
Bliss GVS Pharma Share Holding Pattern
In the latest quarter, Bliss GVS Pharma saw a drop in promoter holding to 35.01%, while DII stake increased to 9.46%, FII holding fell to 8.07%, and public shareholding moved down to 47.45% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Bliss GVS Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Aug 13, 2026, 01:33 AM IST IST | Bliss GVS Pharma - Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019 |
| Aug 13, 2026, 01:25 AM IST IST | Bliss GVS Pharma - Outcome Of Board Meeting Held On Wednesday, August 12, 2026 |
| Aug 13, 2026, 01:10 AM IST IST | Bliss GVS Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, August 12, 2026 |
| Aug 11, 2026, 11:21 PM IST IST | Bliss GVS Pharma - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Aug 05, 2026, 10:37 PM IST IST | Bliss GVS Pharma - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, August 12, 2026 |
Source: Dion Global
About Bliss GVS Pharma
Bliss GVS Pharma Ltd. is a Public Limited Listed company incorporated on 11/12/1984 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1984PLC034771 and registration number is 034771. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 729.81 Cr. and Equity Capital is Rs. 10.58 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- Address102, Hyde Park, Mumbai Maharashtra 400072
- Contact
Source: Dion Global
Management
- Mr. Nandkumar K ChodankarChairman & Ind.Director
- Mr. Narsimha Shibroor KamathManaging Director & CEO
- Ms. Shilpa BhatiaIndependent Woman Director
- Mr. Vijayanarayanan MahadevanIndependent Director
- Mr. Deepak R ShahIndependent Director
FAQs on Bliss GVS Pharma Share Price
What is the share price of Bliss GVS Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Bliss GVS Pharma is ₹545.45 as on Aug 18, 2026.
What kind of stock is Bliss GVS Pharma?
The Bliss GVS Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Bliss GVS Pharma?
The market cap of Bliss GVS Pharma is ₹5,796.78 Cr as on Aug 18, 2026.
What are today's High and Low prices of Bliss GVS Pharma?
Today’s highest and lowest price of Bliss GVS Pharma are ₹545.45 and ₹504.10.
What are the 52 Week High and 52 Week Low of Bliss GVS Pharma?
The 52-week high/low is the highest and lowest price at which Bliss GVS Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Bliss GVS Pharma is ₹552.90 and 52-week low of Bliss GVS Pharma is ₹118.35 as on Aug 18, 2026.
How has the Bliss GVS Pharma performed historically in terms of returns?
The Bliss GVS Pharma has shown returns of 5.0% over the past day, 11.46% for the past month, 90.28% over 3 months, 212.76% over 1 year, 80.14% across 3 years, and 37.84% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Bliss GVS Pharma?
P/E ratio of and PB ratio of Bliss GVS Pharma are 42.56 and 4.86 on Aug 18, 2026. While the company gives a dividend yield of 0.28 per annum.
Source: Dion Global
✕